Discontinuation of thioridazine. Risks must be balanced (Q33812605)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Discontinuation of thioridazine. Risks must be balanced	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

title

Discontinuation of thioridazine. Risks must be balanced (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

author name string

Ann F Bisset

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

published in

The BMJ

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

volume

325

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

issue

7370

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

page(s)

967

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

cites work

Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124456

retrieved

4 July 2018

Timing of new black box warnings and withdrawals for prescription medications

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124456

retrieved

4 July 2018

Risperidone as add‐on therapy in behavioural disturbances in mental retardation: a double‐blind placebo‐controlled cross‐over study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124456

retrieved

30 October 2018

Chronic treatment with eltoprazine does not lead to tolerance in its anti-aggressive action, in contrast to haloperidol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12399356

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BMJ.325.7370.967/A

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

PMC publication ID

1124456

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

PubMed publication ID

12399356

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12399356

retrieved

29 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33812605&oldid=2050673570"